Quant Biomarkers
Advancing Healthy Longevity Through Predictive Biomarkers
Quant Biomarkers is a Swiss life science technology company dedicated to advancing healthy longevity through predictive biomarker-based platforms for early detection of chronic diseases and personalized medical interventions targeting the biology of aging.
Overview
Quant Biomarkers is a Swiss life science technology company dedicated to advancing healthy longevity through innovative biomarker technologies. The company specializes in the development of predictive biomarker-based platforms aimed at the early detection and prognostics of chronic diseases, as well as identifying new therapeutic targets for regenerative medicine.
Key features of Quant Biomarkers include AI-based algorithms for disease risk predictions, personalized medical intervention protocols, and the creation of tissue-specific biomarker panels for diagnostic use. The company utilizes a combination of longitudinal clinical data, health records, and research data, complemented by in-vitro and in-vivo models, proprietary assays, and artificial intelligence to enhance decision-making that improves the quality of an individual's lifespan.
The target audience for Quant Biomarkers includes healthcare providers and individuals seeking early diagnostics and personalized interventions for aging-related diseases. The main benefits of their offerings are the potential for improved health outcomes through early detection, personalized medical interventions, and the optimization of health throughout an individual's lifetime.
Screenshots & Videos
Pricing Plans
| Basic Plan | Pro Plan |
|---|---|
Contact for pricing USD monthly | Contact for pricing USD monthly |
No details available | No details available |
Pros (8)
- Focus on advancing healthy longevity
- Predictive biomarker-based platforms for early detection of chronic diseases
- Targeting biology of aging for disease prevention
- Combines longitudinal clinical, health records & research data
- Utilizes in-vitro, in-vivo models, proprietary assays, and Artificial Intelligence
- Specializes in quantitative assessment of biomarkers of human longevity
- Development of personalized biomarker panels for interventions in aging diseases
- Partnerships with health care providers for early diagnostics
Alternatives of Quant Biomarkers
Compare all alternativesReviews & Ratings
No reviews yet — be the first to review.
Visit Quant Biomarkers to leave a reviewJob Roles
Explore other products in Biotechnology
Agricultural
leveraging AI/ML solutions to develop autonomous robots that handle important agricultural tasks such as harvesting crops at a much faster pace than humans.
Animal
Animal farming involves tracing of animals that allows tracking the whole production process to be made available even to consumers and stakeholders via data collection and evaluation.
Bioinformatics
Combination of omics data with bioinformatics and ML will enable moving from data that are of explanatory nature to application in fields such as medicine.
Forest
Forest biotechnology, especially genetic engineering is very important because plantation forests, for example, are urgently needed to sustainably meet global demand for wood.
Medical
To revolutionize medical biotechnology by enabling the faster, more accurate and more cost-effective identification and development beyond new drugs.
Top AI tools for Quant Biomarkers
Loading...